AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
Expression profiling of human tumors: The end of surgical pathology?
Authors: Ladanyi, M Chan, WC Triche, TJ Gerald, WL
Citation: M. Ladanyi et al., Expression profiling of human tumors: The end of surgical pathology?, J MOL DIAGN, 3(3), 2001, pp. 92-97
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
Authors: Khan, J Wei, JS Ringner, M Saal, LH Ladanyi, M Westermann, F Berthold, F Schwab, M Antonescu, CR Peterson, C Meltzer, PS
Citation: J. Khan et al., Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, NAT MED, 7(6), 2001, pp. 673-679
Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification
Authors: Chen, BY Jhanwar, SC Ladanyi, M
Citation: By. Chen et al., Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification, DIAGN MOL P, 10(2), 2001, pp. 100-104
Fusions of the SYT and SSX genes in synovial sarcoma
Authors: Ladanyi, M
Citation: M. Ladanyi, Fusions of the SYT and SSX genes in synovial sarcoma, ONCOGENE, 20(40), 2001, pp. 5755-5762
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
Authors: Ladanyi, M Lui, MY Antonescu, CR Krause-Boehm, A Meindl, A Argani, P Healey, JH Ueda, T Yoshikawa, H Meloni-Ehrig, A Sorensen, PHB Mertens, F Mandahl, N van den Berghe, H Sciot, R Dal Cin, P Bridge, J
Citation: M. Ladanyi et al., The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25, ONCOGENE, 20(1), 2001, pp. 48-57
Correspondence re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, SwansonPE, Dehner LP, Humphrey PA, Pfeifer JD: Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod Pathol 2000;13 : 1336-46.
Authors: Ladanyi, M Woodruff, JM Scheithauer, BW Bridge, JA Barr, FG Goldblum, JR Fisher, C Perez-Atayde, A Dal Cin, P Fletcher, CDM Fletcher, JA
Citation: M. Ladanyi et al., Correspondence re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, SwansonPE, Dehner LP, Humphrey PA, Pfeifer JD: Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. Mod Pathol 2000;13 : 1336-46., MOD PATHOL, 14(7), 2001, pp. 733-735
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis
Authors: Meyers, PA Krailo, MD Ladanyi, M Chan, KW Sailer, SL Dickman, PS Baker, DL Davis, JH Gerbing, RB Grovas, A Herzog, CE Lindsley, KL Liu-Mares, W Nachman, JB Sieger, L Wadman, J Gorlick, RG
Citation: Pa. Meyers et al., High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis, J CL ONCOL, 19(11), 2001, pp. 2812-2820
Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?
Authors: Fletcher, CDM Fletcher, JA Cin, PD Ladanyi, M Woodruff, JM
Citation: Cdm. Fletcher et al., Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?, HISTOPATHOL, 39(1), 2001, pp. 100-101
Monophasic and biphasic synovial sarcomas abundantly express cancer/testisantigen NY-ESO-1 but not MAGE-A1 or CT7
Authors: Jungbluth, AA Antonescu, CR Busam, KJ Iversen, K Kolb, D Coplan, D Chen, YT Stockert, E Ladanyi, M Old, LJ
Citation: Aa. Jungbluth et al., Monophasic and biphasic synovial sarcomas abundantly express cancer/testisantigen NY-ESO-1 but not MAGE-A1 or CT7, INT J CANC, 94(2), 2001, pp. 252-256
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell
Authors: Mora, J Cheung, NKV Juan, G Illei, P Cheung, I Akram, M Chi, S Ladanyi, M Cordon-Cardo, C Gerald, WL
Citation: J. Mora et al., Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell, CANCER RES, 61(18), 2001, pp. 6892-6898
Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor
Authors: Bridge, JA Kanamori, M Ma, ZG Pickering, D Hill, DA Lydiatt, W Lui, MY Colleoni, GWB Antonescu, CR Ladanyi, M Morris, SW
Citation: Ja. Bridge et al., Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor, AM J PATH, 159(2), 2001, pp. 411-415
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma - A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents
Authors: Argani, P Antonescu, CR Illei, PB Lui, MY Timmons, CF Newbury, R Reuter, VE Garvin, AJ Perez-Atayde, AR Fletcher, JA Beckwith, JB Bridge, JA Ladanyi, M
Citation: P. Argani et al., Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma - A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents, AM J PATH, 159(1), 2001, pp. 179-192
Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma - Absence in predominantly myxoid well-differentiated liposarcomas
Authors: Antonescu, CR Elahi, A Humphrey, M Lui, MY Healey, JH Brennan, MF Woodruff, JM Jhanwar, SC Ladanyi, M
Citation: Cr. Antonescu et al., Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma - Absence in predominantly myxoid well-differentiated liposarcomas, J MOL DIAGN, 2(3), 2000, pp. 132-138
Molecular pathology and molecular pharmacology of osteosarcoma
Authors: Ladanyi, M Gorlick, R
Citation: M. Ladanyi et R. Gorlick, Molecular pathology and molecular pharmacology of osteosarcoma, PEDIAT PATH, 19(5), 2000, pp. 391-413
Monoclonality of multifocal myxoid liposarcoma: Confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements
Authors: Antonescu, CR Elahi, A Healey, JH Brennan, MF Lui, MY Lewis, J Jhanwar, SC Woodruff, JM Ladanyi, M
Citation: Cr. Antonescu et al., Monoclonality of multifocal myxoid liposarcoma: Confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements, CLIN CANC R, 6(7), 2000, pp. 2788-2793
Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias
Authors: Colleoni, GWB Jhanwar, SC Ladanyi, M Chen, BY
Citation: Gwb. Colleoni et al., Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias, DIAGN MOL P, 9(4), 2000, pp. 203-209
SYT-SSX fusion transcripts and epithelial differentiation in synovial sarcoma - Reply
Authors: Ladanyi, M
Citation: M. Ladanyi, SYT-SSX fusion transcripts and epithelial differentiation in synovial sarcoma - Reply, DIAGN MOL P, 9(4), 2000, pp. 235-235
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma
Authors: Antonescu, CR Kawai, A Leung, DH Lonardo, F Woodruff, JM Healey, JH Ladanyi, M
Citation: Cr. Antonescu et al., Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma, DIAGN MOL P, 9(1), 2000, pp. 1-8
Primary renal synovial sarcoma - Molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney
Authors: Argani, P Faria, PA Epstein, JI Reuter, VE Perlman, EJ Beckwith, JB Ladanyi, M
Citation: P. Argani et al., Primary renal synovial sarcoma - Molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney, AM J SURG P, 24(8), 2000, pp. 1087-1096
Cytokeratin immunoreactivity in Ewing's sarcoma - Prevalence in 50 cases confirmed by molecular diagnostic studies
Authors: Gu, M Antonescu, CR Guiter, G Huvos, AG Ladanyi, M Zakowski, MF
Citation: M. Gu et al., Cytokeratin immunoreactivity in Ewing's sarcoma - Prevalence in 50 cases confirmed by molecular diagnostic studies, AM J SURG P, 24(3), 2000, pp. 410-416
Contribution of molecular genetic data to the classification of sarcomas
Authors: Ladanyi, M Bridge, JA
Citation: M. Ladanyi et Ja. Bridge, Contribution of molecular genetic data to the classification of sarcomas, HUMAN PATH, 31(5), 2000, pp. 532-538
Prognostic impact of P53 status in Ewing sarcoma
Authors: de Alava, E Antonescu, CR Panizo, A Leung, D Meyers, PA Huvos, AG Pardo-Mindan, FJ Healey, JH Ladanyi, M
Citation: E. De Alava et al., Prognostic impact of P53 status in Ewing sarcoma, CANCER, 89(4), 2000, pp. 783-792
Prognostic impact of INK4A deletion in Ewing sarcoma
Authors: Wei, G Antonescu, CR de Alava, E Leung, D Huvos, AG Meyers, PA Healey, JH Ladanyi, M
Citation: G. Wei et al., Prognostic impact of INK4A deletion in Ewing sarcoma, CANCER, 89(4), 2000, pp. 793-799
Aberrant ALK tyrosine kinase signaling - Different cellular lineages, common oncogenic mechanisms?
Authors: Ladanyi, M
Citation: M. Ladanyi, Aberrant ALK tyrosine kinase signaling - Different cellular lineages, common oncogenic mechanisms?, AM J PATH, 157(2), 2000, pp. 341-345
ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)
Authors: Colleoni, GWB Bridge, JA Garicochea, B Liu, J Filippa, DA Ladanyi, M
Citation: Gwb. Colleoni et al., ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35), AM J PATH, 156(3), 2000, pp. 781-789
Risultati: 1-25 | 26-38